DGAP-News: Rentschler Biopharma is once again featured on Germany's top-ranked employers list
DGAP-News: Rentschler Biopharma SE / Key word(s):
Rentschler Biopharma is once again featured on Germany's top-ranked employers list
Laupheim, Germany, and Milford, MA, USA, October 9, 2019 - Rentschler Biopharma SE, a world-class contract development and manufacturing organization (CDMO) for biopharmaceuticals, has been featured on the annual list of Germany's best employers for the second year in a row. The analysis of "Germany's most attractive employers" was published by the F.A.Z. Institute today and evaluates the largest German companies from over 150 different sectors for their reputation as employers. Of the 10,000 companies included, 503 were recognized as top employers. Rentschler Biopharma once again ranked number two in the biotechnology sector.
"What drives all of us at Rentschler Biopharma, is our mission to help patients with serious or rare diseases. To achieve this, we are using our development and manufacturing expertise to translate medical research into outstanding biopharmaceuticals," Dr. Frank Matthias, CEO of Rentschler Biopharma, commented. "We are extremely proud to be named one of Germany's best workplaces and I warmly thank all of our employees, who have played an important role in this achievement. Our goal is to retain our highly experienced team while also attracting new talent by offering excellent opportunities for professional and personal growth. This award validates the high priority we have placed on investing in our employees, and we will continue to do so going forward."
In addition to competitive salary packages, Rentschler Biopharma is committed to a family-friendly and collaborative working environment. The Company offers modern benefits, such as a corporate health program and a daycare center at its Laupheim location. The Company's flat hierarchy and management accessibility enable fast decision making. Rentschler Biopharma is a leader in innovation and technology, providing employees the opportunity to be part of cutting-edge and groundbreaking projects.
"Rentschler Biopharma is a first-class biopharmaceutical CDMO with locations in Laupheim, Germany, and Milford in the greater Boston area as well as strategic alliance partner Rentschler Fill Solutions in Austria, and serves clients around the globe. Through our in-house training center, the biosimulator, we can offer our employees customized professional development programs. We also encourage their creative input and independent decision making. We continue to grow and thus are able to offer new opportunities for highly experienced employees and younger team members who want to proactively drive change with passion and entrepreneurial spirit," added Dr. Mathias. Dr. Mathias - together with Prof. Dr. Nikolaus Rentschler, Chairman of the Supervisory Board - is a finalist for the German "Ernst & Young Entrepreneur Of The Year 2019" Award.
Current vacancies can be found here.
About the study "Germany's most attractive
About Rentschler Biopharma SE
09.10.2019 Dissemination of a Corporate News,
transmitted by DGAP - a service of EQS Group AG.
EQS Group is a leading international technology provider for Digital Investor Relations, Corporate Communications and Compliance. More than 8,000 companies worldwide trust EQS’s products and services to securely, efficiently, and simultaneously fulfil complex national and international disclosure and compliance requirements, and to reach stakeholders globally.
- Diversified Healthcare Trust Prices $1 Billion of 9.750% Senior Notes due 2025
- Immutep Receives US$2.4 Million R&D Tax Incentive from French Government
- Statement From The Ad Hoc Bondholder Group
- Dine Brands Global, Inc. Announces CEO Search
- DGAP-News: Crestview Exploration Inc. Hires European Marketing Firm and Provides Update On its Castile and Divide Projects in Nevada
- Crestview Exploration Inc. Hires European Marketing Firm and Provides Update On its Castile and Divide Projects in Nevada